Editas Medicine is up a bit on the day, funds flowing in kept the price up 2.87% since yesterday.
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Editas Medicine hasn't shown a lot of strength recently, shareholders don't seem that energized about the Biotechnology company's future prospects. EDIT might find some support at the 5.035 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts are pretty neutral on Editas Medicine right now, so not much useful information here. The current Analysts Sentiment Score is 8.76. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2024-02-29 Barclays increased their price target by 10% to $11.00. JPMorgan Chase & Co. provided a price target boost of 12.5% to $9.00 from $8.00 on 2024-02-27. Truist Financial decided to move up their price target on 2023-12-12 to $20.00 which is a 33.33% increase. Citigroup upgraded from Neutral to Buy on 2023-10-24 and provided a price target of $11.00. Cantor Fitzgerald released a downgrade on 2023-10-17 from Overweight to Neutral. Stifel Nicolaus upgraded from Hold to Buy on 2023-09-28 and also increased their price target by 88.89% to $17.00. Oppenheimer reiterated a rating of Market Perform on 2023-08-03 and added a price target of $12.00. Chardan Capital decided to move down their price target on 2023-08-02 to $19.00 which is a -13.64% decrease. Raymond James upgraded from Market Perform to Outperform on 2023-06-12 and added a price target of $17.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
EDIT | 8.76 | 5.66 | -2.68 | 14.98 | -0.45 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
EDIT | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
EDIT | 16.41 | %20.1152 | 11.2 | 7.128 | 16420000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 95 | -1.38 | -5.05 | 2.01 | 3.44 | -2.54 | 16.95 | 60.02 | 15.94 | 7.39 | 3.52 | -11603.84 | -10504.58 | 32.63 | 0.00 | 9.36 | 19.48 |
Healthcare | 232 | -1.40 | -4.35 | 2.08 | 4.26 | 1.26 | 15.91 | 60.88 | 13.18 | 9.55 | 5.15 | -10990.44 | -11761.91 | 29.63 | 0.00 | 6.73 | 12.77 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
EDIT |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BEAM | Beam Therapeutics Inc. Co | 1.61 | -3.60 | -12.63 | -4.70 | -10.55 | -37.89 | -7.32 | 58 | -2.18 | -3.75 | -5.52 | -3185.59 | -2418.29 | 0 | 0 | 18.782 |
NTLA | Intellia Therapeutics, In | 1.56 | -5.78 | -12.12 | -8.11 | -23.71 | -34.20 | -47.68 | 66 | -6.19 | -21.76 | -39.61 | -25469.05 | -4705.40 | 125 | 0 | 10.4627 |
TWST | Twist Bioscience Corporat | 1.52 | -8.25 | -15.08 | -16.49 | -29.98 | -2.26 | 56.86 | 60 | 84.42 | 69.88 | 97.40 | -350.71 | -17472.30 | 100 | 0 | 23.3961 |
CRSP | CRISPR Therapeutics AG | 1.48 | -1.39 | -6.50 | -5.08 | -31.17 | -43.46 | -12.66 | 53 | -12.36 | -5.71 | -2.53 | -6925.39 | -2012.49 | 0 | 0 | 15.3247 |
TDOC | Teladoc Health, Inc. | 1.3 | -2.09 | 4.74 | 5.03 | -26.37 | -51.30 | -66.74 | 54 | -190.11 | -95.65 | -112.32 | -87747.32 | -175.00 | 0 | 0 | 8.78425 |
IOVA | Iovance Biotherapeutics, | 1.26 | -4.30 | -14.15 | 0.91 | 17.35 | -36.24 | 72.59 | 54 | -7.19 | -2.97 | -3.50 | -10137.54 | -3081.34 | 0 | 0 | 15.0071 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.